2020
DOI: 10.1186/s40814-020-00721-y
|View full text |Cite
|
Sign up to set email alerts
|

Healthy Eating and Active Lifestyle After Bowel Cancer (HEAL ABC): feasibility randomised controlled trial protocol

Abstract: Background Targeting modifiable lifestyle factors including diet and physical activity represents a potentially cost-effective strategy that could support a growing population of colorectal cancer survivors and improve their health outcomes. Currently, effective, evidence-based interventions and resources helping people after bowel cancer to adopt new lifestyle habits are lacking. The aim of this trial is to test the Healthy Eating and Active Lifestyle After Bowel Cancer (HEAL-ABC) intervention… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 55 publications
0
3
0
Order By: Relevance
“…This chapter describes the methods used in the feasibility study. The study protocol for this PhD was published (Sremanakova et al, 2020).…”
Section: Chapter 5 Methods -Study Protocolmentioning
confidence: 99%
See 1 more Smart Citation
“…This chapter describes the methods used in the feasibility study. The study protocol for this PhD was published (Sremanakova et al, 2020).…”
Section: Chapter 5 Methods -Study Protocolmentioning
confidence: 99%
“…The study was successfully completed, and minimal changes due to Covid19 were introduced compared to the published protocol (Sremanakova et al, 2020). The study was deemed feasible based on criteria for methodological issues that could arise during the conduct of the study (Shanyinde et al, 2011) and the intervention was delivered as intended based on the fidelity assessment criteria (Bellg et al, 2004).…”
Section: Feasibilitymentioning
confidence: 99%
“…The study was approved by the North West Greater Manchester South Research Ethics Committee (IRAS ID 273818), and registered on the National Institute of Health Clinical Trials register (NCT04227353). Trial protocol was published (25). The COVID-19 global pandemic resulted in some deviations from the original study protocol.…”
Section: Trial Designmentioning
confidence: 99%